Vetoquinol Company Description

Vetoquinol SA, a veterinary pharmaceutical company, designs, develops, and sells veterinary drugs and non-medicinal products in Europe, the Americas, and the Asia Pacific region.

It provides products in the areas of mobility, pain, and inflammation; dermatology, hygiene, and care; anti-parasite; udder health; infectious diseases; reproduction; behavior management; internal medicine; and cardiology-nephrology for cattle, sheep, pigs, poultry, dogs, cats, and horses.

The company was founded in 1933 and is headquartered in Lure, France. Vetoquinol SA is a subsidiary of Soparfin SCA.

Vetoquinol SA

Country	France
Founded	1933
Industry	Drug Manufacturers - Specialty & Generic
Sector	Healthcare
Employees	2,440
CEO	Matthieu Frechin

Contact Details

Address: Magny-Vernois Lure, 70204 France
Phone	33 3 84 62 55 55
Website	vetoquinol.com

Stock Details

Ticker Symbol	VETO
Exchange	Euronext Paris
Fiscal Year	January - December
Reporting Currency	EUR
ISIN Number	FR0004186856
SIC Code	2834

Key Executives

Name	Position
Matthieu Frechin	Chief Executive Officer and Non-Independent Chairman of the Board
Alain Masson	Deputy Chief Executive Officer and Pharmacist Manager
Regis Vimal du Monteil	Chief Financial Officer
Dominique Derveaux	Chief Operations Officer
Philippe Gruet	Chief Scientific Officer
Sandrine Perrier	Chief Information Officer
Laurent Thore	Director of Partnerships, Legal Affairs and Risks
Xavier Berthet	Director of Group Communications
Isabelle Proust-Cabrera	Group Director of Human Resources